English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3929]
News [11494]
Articles [47]
Editorials [10]
Conferences [201]
elearning [4]
Research explores how T-cells detect cancer
Research explores how T-cells detect cancer
New technology to improve cancer detection and treatment
New technology to improve cancer detection and treatment
Study shows potential for new radiopharmaceutical cancer treatment
Study shows potential for new radiopharmaceutical cancer treatment
DNA methylation makes cancer cells more vulnerable to immune response
DNA methylation makes cancer cells more vulnerable to immune response
Severe herpesvirus infection beats adult T-cell leukaemia/lymphoma
Severe herpesvirus infection beats adult T-cell leukaemia/lymphoma
People with the gene mutation BRCA1 may face greater risk of developing aggressive cancer caused by asbestos exposure
People with the gene mutation BRCA1 may face greater risk of developing aggressive cancer caused by asbestos...
Endocytoscopy - A new type of digestive endoscopy that can diagnose small, early oesophageal cancers without biopsy
Endocytoscopy - A new type of digestive endoscopy that can diagnose small, early oesophageal cancers without biopsy
Study identifies potential therapeutic target for triple-negative breast cancer in Black patients
Study identifies potential therapeutic target for triple-negative breast cancer in Black patients
ASCO GU 2023: Polymerase inhibitor significantly improves progression-free survival for metastatic prostate cancer
ASCO GU 2023: Polymerase inhibitor significantly improves progression-free survival for metastatic prostate cancer
Ponatinib more effective than imatinib for newly diagnosed Ph+ALL leukaemia patients
Ponatinib more effective than imatinib for newly diagnosed Ph+ALL leukaemia patients
<1...290291292293294...1150>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top